This suggests that Ang1 supplementation may be counterproductive, even if not detrimental, in terms of controlling localized primary tumor growth; however, this aforementioned study did not model metastatic disease, where the impact may be fundamentally different (Guerin et al, 2013). This evidence concerns the gene ANGPT1 and metastatic neoplasm.